Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus with Cyclophosphamide and Dexamethasone in Relapsed Myeloma
2005-000656-33Phase 2Completed
- Sponsor
- Royal Devon University Healthcare NHS Foundation Trust
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus, cyclophosphamide and dexamethasone in multiple myeloma (MM), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoints: Maximum tolerated dose of weekly cyclophosphamide and Toxicity of combination therapy. Started May 2005; status: completed.
02
Drugs
sirolimuscyclophosphamidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-000656-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000656-33.